Long COVID in cancer patients: preponderance of symptoms in majority of patients over long time periodHiba Dagher, Issam Raad, Bruno Granwehr et al.|eLife|2023Cited by 42
A randomized non-inferiority study comparing imipenem/cilastatin/relebactam with standard-of-care Gram-negative coverage in cancer patients with febrile neutropeniaAnne‐Marie Chaftari, Issam Raad, Hiba Dagher et al.|Journal of Antimicrobial Chemotherapy|2024Cited by 11
Procalcitonin Level Monitoring in Antibiotic De-Escalation and Stewardship Program for Patients with Cancer and Febrile NeutropeniaHiba Dagher, Issam Raad, Anne‐Marie Chaftari et al.|Cancers|2024Cited by 8